First Affiliated Hospital of Guangxi Medical University — Nanning, Guangxi

Which of these are you?

🧭 Patient, caregiver or referring clinician

This page counts public registry records — it is not a list of trials you can join.

Studies recruiting near Nanning →

Never medical advice — always discuss trial participation with your own doctor first.

🏢 I work at this facility, a sponsor or a CRO

Verify and correct how this facility appears in public registry records — free — and open the full registry-entry list below.

Verify this profile →

Public research footprint of First Affiliated Hospital of Guangxi Medical University, compiled from the ClinicalTrials.gov public registry.

290

Registered studies

161

Active

90

Recruiting now

57

Completed

13

Stopped or withdrawn

Most-studied conditions

Multiple Myeloma · Acute Respiratory Distress Syndrome (ARDS) · Immune Thrombocytopenic Purpura (ITP) · Chronic Lymphocytic Leukemia

Recently updated registry entries

NCT06073821 — Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax… (Active Not Recruiting)
NCT06722235 — A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia (Recruiting)
NCT06948318 — A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia (Recruiting)

7 more recent registry entries at this facility

Research staff — enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.